MAPKs activation in head and neck squamous cell carcinomas
Cancer of head and neck (HN) represents a diffused group of neoplasia; despite advances in clinical treatment its mortality rate has remained high, mainly because it is frequently diagnosed only at an advanced stage. Molecular markers allowing the diagnosis at an early stage would be useful. Mitogen...
Saved in:
Main Authors: | Daniele Maggioni (Author), Renato Gaini (Author), Gabriella Nicolini (Author), Giovanni Tredici (Author), Werner Garavello (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2011-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Immunotherapy in head and neck squamous cell carcinoma and rare head and neck malignancies
by: Stefano Cavalieri, et al.
Published: (2021) -
Docetaxel in the treatment of squamous cell carcinoma of the head and neck
by: Alexander Rapidis, et al.
Published: (2008) -
Cancer stem cells in head and neck squamous cell carcinoma
by: Harish A Kumar, et al.
Published: (2023) -
Bibliometric analysis of immunotherapy for head and neck squamous cell carcinoma
by: Xin-Jia Cai, et al.
Published: (2023) -
MicroRNA Deregulations in Head and Neck Squamous Cell Carcinomas
by: Muzaffar Shah-Khan, et al.
Published: (2013)